Equities

KDA Group Inc

KDA Group Inc

Actions
  • Price (CAD)0.285
  • Today's Change-0.045 / -13.64%
  • Shares traded446.13k
  • 1 Year change+280.00%
  • Beta1.3125
Data delayed at least 15 minutes, as of Jun 14 2024 20:59 BST.
More ▼
Improved Notifications for Markets Data Alerts
Improved Notifications for Markets Data Alerts
Want push notifications sent directly to your devices for equity price changes and breaking news stories? Let us know here.
 
Existing alertsView our existing alerts
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

KDA Group Inc. is a Canada-based solution and services provider to pharmacies and pharmaceutical companies in Canada as well as technological platform for the health industry. The Company’s segments include Pharmacy Services, Pharmaceutical Solutions and Pharmaceutical Technology. Its Pharmacy Services segment offers training, consulting, and replacement services for professional resources in the field of healthcare. Its Pharmaceutical Solutions segment is engaged in the development and integration of technological platforms dedicated to all healthcare professionals. Its Pharmaceutical technology segment offers KRX, KRX DENTAL and ADRX platforms. It also offers ZRx Digital Prescriber an electronic prescriber computer and mobile software designed and developed for use by healthcare providers who are authorized to prescribe medications and other treatments. Its subsidiaries include Alliance Pharma Operations Inc., Elitis Pharma Inc., Logistik Pharma Inc. and Groupe Technologique KDA Inc.

  • Revenue in CAD (TTM)186.28k
  • Net income in CAD133.66k
  • Incorporated2008
  • Employees--
  • Location
    KDA Group Inc300-1351 RUE Notre-Dame ETHETFORD MINES G6G 0G5CanadaCAN
  • Phone+1 (418) 755-0821
  • Fax+1 (418) 755-0821
  • Websitehttp://www.alliancepharma.ca/
More ▼

Peer analysis

Key Information
CompanyRevenue (TTM)Net income (TTM)Market capEmployeesPrice/earnings (TTM)Price/book value (MRQ)Price/cash flow (TTM)Price/sales (TTM)EPS (excl. extraordinary items, TTM)EPS (incl. extraordinary items, TTM)Revenue per share (TTM)Book value per share (MRQ)Asset turnover (TTM)Inventory turnover (TTM)Receivables turnover (TTM)Revenues per employee (TTM)Return on avg assets (TTM)Return on avg assets (5 yr avg)Return on investment (TTM)Return on investment (5 yr avg)Gross margin (TTM)Gross margin
(5 yr avg)
Net profit margin (TTM)Net Profit margin
(5 yr avg)
Quick ratio (MRQ)Interest coverage (TTM)Total debt to capital (MRQ)Payout ratio
(5 yr avg)
Revenue
(YOY change %)
Revenue
(5 yr growth rate)
Net income
(YOY change %)
Net income
(5 yr growth rate)
Capital expenditure
(5 yr growth rate)
Dividend
(5 yr growth rate)
Medexus Pharmaceuticals Inc158.95m8.08m37.91m98.004.240.93372.350.23850.36590.36597.311.660.75472.195.441,621,921.003.83-6.838.44-9.7952.9153.905.08-11.450.70130.94260.6388--40.9369.17142.41---8.59--
Immunoprecise Antibodies Ltd23.68m-14.26m37.95m102.00--0.7618--1.60-0.4121-0.41210.68321.380.29395.256.76169,018.60-17.70-23.62-19.62-27.2551.8857.18-60.23-76.181.38--0.2241--6.7230.59-58.96--34.04--
Eastwood Bio-Medical Canada Inc736.75k-531.60k41.33m--------56.10-0.0077-0.00770.0107-0.0131.63--38.65---117.75-52.23---140.2960.0052.09-72.15-52.90---227.16-----33.223.13-264.69------
IntelGenx Technologies Corp.1.44m-15.15m41.92m48.00------29.04-0.0868-0.08680.0083-0.12080.124514.361.74---130.62-75.15---133.79-66.03---1,049.48-819.850.1153-4.8823.66--9.37-10.657.14---30.32--
Microbix Biosystems Inc23.84m4.06m44.50m69.0010.991.618.151.870.02960.02960.1730.2020.67031.676.33--11.42-0.972912.72-1.1754.3852.3017.04-1.554.983.530.1948---13.435.71-102.21---3.56--
MustGrow Biologics Corp4.71m-665.06k47.18m0.00--10.42--10.01-0.0134-0.01340.09360.09120.7632--45.31---10.77-50.41-14.00-59.28-----14.11-298.73----0.1393--72,619.13372.5487.84------
Covalon Technologies Ltd26.24m-2.77m49.88m----2.48--1.90-0.1123-0.11231.060.80211.021.844.53---10.83-18.06-12.67-27.1055.8451.89-10.57-27.064.85--0.0597--46.56-0.09651.79--12.21--
KDA Group Inc186.28k133.66k49.99m--141.793.2257.22268.350.0020.09260.00120.08860.0079--0.0693---0.4146-17.96-0.8534-44.6936.5126.76-52.24-28.00---4.310.1287---22.20-62.03106.88--31.67--
LSL Pharma Group Inc12.17m-4.62m51.84m----3.22--4.26-0.056-0.0560.14660.14890.39292.594.87---14.92---21.69--19.76---37.97--0.4505-0.84650.4938--------------
Helix Biopharma Corp.0.00-5.65m58.83m9.00---------0.0277-0.02770.00-0.00120.00----0.00-318.95-261.49-574.76-------------2,825.00--------4.16---28.36--
Simply Better Brands Corp95.08m-30.01m59.65m--------0.6274-0.4156-0.43051.32-0.08542.7112.6817.69---85.10-63.90-361.23-215.4853.52---31.40-29.460.2536-19.653.20--22.08---96.41------
Satellos Bioscience Inc0.00-21.13m60.91m12.00--1.77-----0.1718-0.17180.000.30590.00----0.00-93.29-107.22-109.86-136.58------------0.00-------40.33--459.46--
Data as of Jun 14 2024. Currency figures normalised to KDA Group Inc's reporting currency: Canadian Dollar CAD
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.